NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
07/07/2026
Back to search
Official data from USPTO
ARISE CANCER CONSORTIUM
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
ARISE CANCER CONSORTIUM
ST13
US500000098761563Class
35, 42
Filing
98761563
Registration
8336942
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
19
Latest update
07/07/2026
Classification
Registered
Trademark type
Word
Nice classes
35, 42
Filing date
09/20/2024
Registration date
07/07/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/07/2026
Last transaction
07/07/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
04/23/2025
First use in commerce
04/23/2025
Drawing code
4
Owner type
99
Owner location
Charlotte, NC, US
Examiner
REID, MONICA R
Law office
N80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
T. A. (pessoa física)
Representatives
Nicole J. Renouard Quarles & Brady LLP
Technical classification
Nice Classes
Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Promoting public interest and awareness of childhood cancer research and survivorship
Class 42
Medical and scientific research in the field of oncology; Medical and scientific researchconducting clinical trials for others; Providing medical and scientific research information in the field of clinical trials; Scientific research for medical purposes in the area of cancerous diseases
Publications
History of USPTO decisions and trademark events.
19 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
07/07/2026
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
06/13/2026
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
06/13/2026
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/07/2026
IUAF
USE AMENDMENT FILED
10/22/2025
EISU
TEAS STATEMENT OF USE RECEIVED
10/22/2025
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/10/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/15/2025
PUBO
PUBLISHED FOR OPPOSITION
04/15/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/09/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/19/2025
XAEC
EXAMINER'S AMENDMENT ENTERED
03/19/2025
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
03/19/2025
GNEA
EXAMINERS AMENDMENT E-MAILED
03/19/2025
CNEA
EXAMINERS AMENDMENT -WRITTEN
03/19/2025
DOCK
ASSIGNED TO EXAMINER
03/18/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/20/2024
NWAP
NEW APPLICATION ENTERED
09/20/2024
Continuous trademark protection
Get notified about every new filing that threatens ARISE CANCER CONSORTIUM or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.